CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD.

Otros idiomas Chengdu Easton Biopharmaceuticals Co., Ltd.

Acciones

688513

CNE100004397

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 21/05/2024			Varia. Cinco días.	Varia. 1 de enero.
57,18 ^CNY	-0,10 %		-1,72 %	-10,35 %

22/04	Chengdu Easton Biopharmaceuticals Co. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
23/02	Chengdu Easton Biopharmaceuticals Co. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Easton Biopharma's Unit Gets Nod to Market Bisoprolol Amlodipine Tablets	16/04
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.	04/01
Chengdu Easton Registers Heart Failure Drug	19/12
Chengdu Easton Biopharmaceuticals Co., Ltd.(XSSC:688513) dropped from S&P Global BMI Index	18/12
Chengdu Easton Biopharma Registers Ibuprofen Injection For Premature Babies	21/11
Chengdu Easton Biopharmaceuticals' Unit Gets US FDA's Nod for Nalmefene Hydrochloride Injection; Shares Rise 5%	17/11
Chengdu Easton Biopharma Registers Hypertension Drug	01/11
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Chengdu Easton Biopharma Registers Blood Pressure Control Drug	24/10/23
Chengdu Easton Biopharma's Antiepileptic Drug Gets Marketing Nod in China	18/10/23
Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.	11/10/23
Easton Biopharma Unit's Production Line Passes US FDA Inspection	25/09/23
Chengdu Easton Biopharmaceuticals Co., Ltd.(XSSC:688513) added to S&P Global BMI Index	18/09/23
Certain A Shares of Chengdu Easton Biopharmaceuticals Co., Ltd. are subject to a Lock-Up Agreement Ending on 2-SEP-2023.	02/09/23
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23
Chengdu Easton Biopharma to Repurchase Up to 200 Million Yuan Shares	15/08/23
Chengdu Easton Biopharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	14/08/23
Chengdu Easton Biopharmaceuticals Co., Ltd. authorizes a Buyback Plan.	14/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Chengdu Easton Biopharmaceuticals Co., Ltd.

Acciones

688513

CNE100004397

Otros idiomas

Filtros